A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2010-08-10
Target enrollment:
Participant gender:
Summary
This trial was conducted in Europe. The aim of this clinical trial was to evaluate the effect
on the blood glucose-lowering effect of NN1250 (insulin degludec) in subjects with type 1
diabetes.